ZEISS and Guangzheng Group Announce Strategic Collaboration on Refractive Intraocular Lenses

At the 2023 CIIE, Carl Zeiss unveiled and showcased the world's first toric trifocal intraocular lens, which is the only toric correction intraocular lens in China capable of covering high myopia under 6D and high astigmatism above 3.75D. It also provides an integrated solution for cataracts, presbyopia, myopia (or hyperopia), and astigmatism. The Carl Zeiss trifocal intraocular lens series has been used in over a million surgical cases worldwide, offering the possibility of excellent vision at all distances for patients with high myopia and high astigmatism.

As an optical pioneer with 177 years of innovative heritage, Carl Zeiss has remained committed to continuous innovation in localization models during its 66 years in China, actively meeting diverse local needs and contributing to China's high-quality development. With the deep advancement of the "Healthy China" strategy, Carl Zeiss leverages its cutting-edge technological advantages to enhance national eye health standards from multiple perspectives, including technological innovation, public awareness, physician training, and industry benchmarks.

In addition, at this CIIE, Carl Zeiss also held a strategic cooperation signing ceremony with Guangzheng Group Co., Ltd. Zhou Yonglin, Chairman of Guangzheng Group Co., Ltd., Zhou Shengying from the Brand Department of Guangzheng Group Co., Ltd., Liu Yonghua, General Manager of Carl Zeiss AG's Medical Division in China, Zhou Jian, Head of the Cataract and Phacoemulsification Surgery Division of Carl Zeiss AG's Medical Division in China, Li Ning, Head of the Refractive Surgery Division of Carl Zeiss AG's Medical Division in China, Wang Jianzhong, Ophthalmology East Regional Sales Director of Carl Zeiss AG's Medical Division in China, Chen Wei, Key Account Manager of Carl Zeiss AG's Medical Division in China, and others attended the signing ceremony.

Chairman of Guangzheng Group Co., Ltd., Zhou Yonglin, stated after the signing, "Guangzheng New World Eye Group and Carl Zeiss have been cooperating for more than ten years. Both parties highly value innovation and the application of new technologies. This CIIE marks a new level of cooperation between the two sides, achieving a strategic transformation."

Liu Yonghua, General Manager of Carl Zeiss Medical Division, stated, "At this CIIE, Guangzheng Group and Carl Zeiss signed a strategic agreement to achieve the transformation of high-end intraocular lenses. In the future, Carl Zeiss will strongly support various training programs of the Optical Group, including doctor training and patient communication training. This signing also includes the 3D digital navigation microscope, which is believed to contribute to the high-end digital transformation of Guangzheng Group."